Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment. (4th November 2015) - Andtbacka, Robert HI; Curti, Brendan D; Hallmeyer, Sigrun; Feng, Zipei; Paustian, Christopher; Bifulco, Carlo; Fox, Bernard; Grose, Mark; Shafren, Darren